Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1890 1
1908 1
1936 1
1937 1
1938 3
1939 2
1940 7
1941 1
1942 4
1943 3
1945 9
1946 25
1947 22
1948 30
1949 19
1950 45
1951 60
1952 45
1953 50
1954 63
1955 73
1956 56
1957 68
1958 43
1959 43
1960 47
1961 41
1962 39
1963 123
1964 168
1965 118
1966 128
1967 132
1968 176
1969 193
1970 191
1971 251
1972 315
1973 330
1974 338
1975 417
1976 365
1977 375
1978 381
1979 419
1980 447
1981 455
1982 469
1983 432
1984 486
1985 475
1986 433
1987 444
1988 434
1989 484
1990 438
1991 440
1992 409
1993 400
1994 400
1995 415
1996 388
1997 383
1998 395
1999 380
2000 367
2001 346
2002 338
2003 355
2004 358
2005 350
2006 384
2007 360
2008 370
2009 357
2010 395
2011 416
2012 429
2013 428
2014 476
2015 454
2016 466
2017 475
2018 491
2019 513
2020 715
2021 852
2022 779
2023 688
2024 609
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24,353 results

Results by year

Filters applied: . Clear all
Page 1
Colchicine in Cardiovascular Disease: In-Depth Review.
Deftereos SG, Beerkens FJ, Shah B, Giannopoulos G, Vrachatis DA, Giotaki SG, Siasos G, Nicolas J, Arnott C, Patel S, Parsons M, Tardif JC, Kovacic JC, Dangas GD. Deftereos SG, et al. Circulation. 2022 Jan 4;145(1):61-78. doi: 10.1161/CIRCULATIONAHA.121.056171. Epub 2021 Dec 29. Circulation. 2022. PMID: 34965168 Free PMC article. Review.
It is considered standard-of-care therapy for pericarditis, and several clinical trials have evaluated its role in postoperative and postablation atrial fibrillation, postpericardiotomy syndrome, coronary artery disease, percutaneous coronary interventions, and cerebrovascular di …
It is considered standard-of-care therapy for pericarditis, and several clinical trials have evaluated its role in postoperative and postabl …
Colchicine's Role in Cardiovascular Disease Management.
Buckley LF, Libby P. Buckley LF, et al. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1031-1041. doi: 10.1161/ATVBAHA.124.319851. Epub 2024 Mar 21. Arterioscler Thromb Vasc Biol. 2024. PMID: 38511324 Free article. Review.
Colchicine-an anti-inflammatory alkaloid-has assumed an important role in the management of cardiovascular inflammation 3500 years after its first medicinal use in ancient Egypt. ...Future research should elucidate the mechanisms of anti-inflammatory effects of colchici …
Colchicine-an anti-inflammatory alkaloid-has assumed an important role in the management of cardiovascular inflammation 3500 years af …
Colchicine in atherosclerotic cardiovascular disease.
Tucker B, Goonetilleke N, Patel S, Keech A. Tucker B, et al. Heart. 2024 Apr 15;110(9):618-625. doi: 10.1136/heartjnl-2023-323177. Heart. 2024. PMID: 38331560 Review.
Inflammation has a direct role in the development of atherosclerotic vascular disease, and oral colchicine displays broad anti-inflammatory properties. Several large, randomised controlled trials (RCTs) have evaluated colchicine's impact on cardiovascular out …
Inflammation has a direct role in the development of atherosclerotic vascular disease, and oral colchicine displays broad anti-inflam …
Colchicine poisoning: the dark side of an ancient drug.
Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y. Finkelstein Y, et al. Clin Toxicol (Phila). 2010 Jun;48(5):407-14. doi: 10.3109/15563650.2010.495348. Clin Toxicol (Phila). 2010. PMID: 20586571 Review.
INTRODUCTION: Colchicine is used mainly for the treatment and prevention of gout and for familial Mediterranean fever (FMF). ...Co-administration with statins may increase the risk of myopathy. MECHANISMS OF TOXICITY: Colchicine's toxicity is an extension of …
INTRODUCTION: Colchicine is used mainly for the treatment and prevention of gout and for familial Mediterranean fever (FMF). ...Co-ad …
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation.
Schwarz N, Fernando S, Chen YC, Salagaras T, Rao SR, Liyanage S, Williamson AE, Toledo-Flores D, Dimasi C, Sargeant TJ, Manavis J, Eddy E, Kanellakis P, Thompson PL, Tan JTM, Snel MF, Bursill CA, Nicholls SJ, Peter K, Psaltis PJ. Schwarz N, et al. FASEB J. 2023 Apr;37(4):e22846. doi: 10.1096/fj.202201469R. FASEB J. 2023. PMID: 36856983
Colchicine is a broad-acting anti-inflammatory agent that has attracted interest for repurposing in atherosclerotic cardiovascular disease. ...At low dose, colchicine's effects were not accompanied by the evidence of microtubule depolymerization. ...
Colchicine is a broad-acting anti-inflammatory agent that has attracted interest for repurposing in atherosclerotic cardiovascular di …
Colchicine in Stable Coronary Artery Disease.
Fiolet ATL, Nidorf SM, Mosterd A, Cornel JH. Fiolet ATL, et al. Clin Ther. 2019 Jan;41(1):30-40. doi: 10.1016/j.clinthera.2018.09.011. Epub 2018 Nov 2. Clin Ther. 2019. PMID: 30396516 Review.
Retrospective cohort studies in patients with gout report a lower incidence of combined cardiovascular outcomes in those treated with colchicine. Thus far, one prospective, randomized clinical trial has provided evidence on a possible protective effect of colchicine …
Retrospective cohort studies in patients with gout report a lower incidence of combined cardiovascular outcomes in those treated with col …
Colchicine and plaque: A focus on atherosclerosis imaging.
Aldana-Bitar J, Golub IS, Moore J, Krishnan S, Verghese D, Manubolu VS, Benzing T, Ichikawa K, Hamal S, Kianoush S, Anderson LR, Ramirez NR, Leipsic JA, Karlsberg RP, Budoff MJ. Aldana-Bitar J, et al. Prog Cardiovasc Dis. 2024 May-Jun;84:68-75. doi: 10.1016/j.pcad.2024.02.010. Epub 2024 Feb 27. Prog Cardiovasc Dis. 2024. PMID: 38423236 Review.
We aim to improve understanding (and thereby application) of colchicine alongside existing mechanisms for CVD event reduction. This paper examines colchicine's anti-inflammatory mechanism, and reviews large cohort studies that evidence colchicine's …
We aim to improve understanding (and thereby application) of colchicine alongside existing mechanisms for CVD event reduction. This p …
Colchicine in Gout: An Update.
Pascart T, Richette P. Pascart T, et al. Curr Pharm Des. 2018;24(6):684-689. doi: 10.2174/1381612824999180115103951. Curr Pharm Des. 2018. PMID: 29336252 Review.
Despite the fact that colchicine is by far the most ancient treatment for gout, new data are still being gathered. In gout, colchicine's ability to block polymerization of tubulin prevents the activation of the inflammasome. ...
Despite the fact that colchicine is by far the most ancient treatment for gout, new data are still being gathered. In gout, colchi …
Colchicine - Renaissance of an "ancient" drug.
Huber SM, Navarini A, Brandt O, Müller S. Huber SM, et al. J Dtsch Dermatol Ges. 2023 Mar;21(3):239-243. doi: 10.1111/ddg.14961. Epub 2023 Mar 9. J Dtsch Dermatol Ges. 2023. PMID: 36892188 Review.
Colchicine, which was already used by the ancient Egyptians, has recently experienced a renaissance in various medical disciplines, including dermatology. However, due to the potentially significant side effects of systemic use, many clinicians are cautious in their use of …
Colchicine, which was already used by the ancient Egyptians, has recently experienced a renaissance in various medical disciplines, i …
Colchicine in dermatology: A review.
Robinson KP, Chan JJ. Robinson KP, et al. Australas J Dermatol. 2018 Nov;59(4):278-285. doi: 10.1111/ajd.12795. Epub 2018 Feb 12. Australas J Dermatol. 2018. PMID: 29430631 Review.
Despite its efficacy in various cutaneous diseases, the use of colchicine may be limited by concerns over its side-effects and the potential for toxicity. This article reviews the current literature on the pharmacology of colchicine and its clinical applications in …
Despite its efficacy in various cutaneous diseases, the use of colchicine may be limited by concerns over its side-effects and the po …
24,353 results
You have reached the last available page of results. Please see the User Guide for more information.